Type II Endometrial Adenocarcinoma — Trials

Type II Endometrial Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 9
Ph III recruiting: 2
Growth YoY: —
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00492778	Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer	unknown	Phase 2	165	GOG FoundationNETWORK	2	Mar 29, 2023	clinicaltrials
NCT02065687	Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer	unknown	Phase 2 / Phase 3	469	Gynecologic Oncology GroupNETWORK	1	Sep 30, 2021	clinicaltrials